臨床藥師參與多學科聯(lián)合診療對COPD患者的療效研究

打開文本圖片集

摘 要 目的：探索臨床藥師與多學科協(xié)作開展對慢性阻塞性肺疾?。–OPD）患者的治療效果。方法：將178例COPD患者隨機分為干預組（n=89）和對照組（n=89），對照組采用常規(guī)治療，干預組在此基礎上采用醫(yī)師、護士、藥師多學科聯(lián)合診療，觀察兩組患者干預效果。結果：干預后，兩組Wmax、GQOLI-74評分、SAS評分、SDS評分變化顯著，且干預組明顯優(yōu)于對照組（P

關鍵詞 多學科聯(lián)合診療 COPD 臨床藥師

中圖分類號：R563 文獻標志碼：A 文章編號：1006-1533（2023）07-0069-04

引用本文 葉進， 周琦， 朱衛(wèi)鋒， 等. 臨床藥師參與多學科聯(lián)合診療對COPD患者的療效研究[J]. 上海醫(yī)藥， 2023， 44（7）： 69-72.

基金項目：浦東新區(qū)老年醫(yī)院科研項目（2021LNYNKT-A02）

Study on the efficacy of clinical pharmacists’ participation in multidisciplinary joint treatment for COPD patients

YE Jin1， ZHOU Qi2， ZHU Weifeng3， YU Teng3

（1. Department of Pharmacy； 2. Medical Department； 3. Department of Respiratory Medicine， Shanghai Pudong Geriatric Hospital， Shanghai 201314， China）

ABSTRACT Objective： To explore the effectiveness of clinical pharmacist and multidisciplinary collaboration in the treatment of patients with chronic obstructive pulmonary disease （COPD）. Methods： One hundred and seventy-eight COPD patients were randomly divided into an intervention group （n=89） and a control group （n=89）. The control group was conventionally treated， and the intervention group was treated with the multidisciplinary collaboration of physicians， nurses and pharmacists besides the conventional treatment， and the intervention effects were observed in the two groups. Results： After the intervention， the changes in Wmax， GQOLI-74 score， SAS score and SDS score were significant in both groups and were significantly better in the intervention group than the control group （P

KEY WORDS multidisciplinary joint diagnosis and treatment； chronic obstructive pulmonary disease； clinical pharmacist

慢性阻塞性肺疾?。╟hronic obstructive pulmonary disease， COPD）是一種常見的、可預防和治療的慢性氣道疾病，其特征是持續(xù)存在的氣流受限和相應的呼吸系統(tǒng)癥狀，通常與顯著暴露于有害顆?；驓怏w相關[1]。（剩余5330字）